Isradipine  Isradipine is a dihydropyridine calcium channel blocker  Change in UPDRS score (Parts I–III) to evaluate long-term benefits of this drug  STEADY-PD III study has recently shown that patients treated with Isradipine did not have any difference in motor symptoms compared to placebo